Clinical Trial Update: Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer [Phase 3]

View source ↗

Summary

Phase III study comparing TAS-118 plus oxaliplatin versus S-1 plus cisplatin in advanced gastric cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)
• TAS-118

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Gastric Cancer | Phase 3 | Status: COMPLETED | Results posted: 2021-12-20